![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
01 Macleods Pharmaceuticals Limited (2)
02 Mylan AB (1)
03 VIIV HEALTHCARE UK LTD (5)
04 ViiV Healthcare GmbH (3)
05 ViiV Healthcare UK Ltd. (3)
01 Abacavir (7)
02 Abacavir; Lamivudine (2)
03 Abacavir; Lamivudine; Zidovudine (1)
04 Dolutegravir; Abacavir; Lamivudine (1)
05 Lamivudine; Abacavir (2)
06 Lamivudine; Abacavir; Dolutegravir (1)
01 Abacavir 20Mg/Ml 240Ml Oral Use (1)
02 Abacavir 300Mg 60 Units Oral Use (1)
03 Abacavir+Lamivudine + Zidovudine 300+150+300Mg 60 Units Oral Use (1)
04 Abacavir+Lamivudine 600+300Mg 30 Joined' Oral Use (1)
05 Antic-calc Tablet, Film Coated (4)
06 Dolutegravir+Abacavir+Lamivudine 50+600+300Mg 30 Joined' Oral Use (1)
07 FILM COATED TABLET (2)
08 Film Tablet (1)
09 Solution (1)
10 Tablet (1)
01 Italy (5)
02 Norway (4)
03 Switzerland (3)
04 United Kingdom (2)
01 Abacavir /Lamivudin Mylan (1)
02 Kivexa (2)
03 Kivexa, Filmtabl 600mg/300mg, 30 Stk (1)
04 Triumeq (2)
05 Trizivir (1)
06 Ziagen (3)
07 Blank (4)